tirzepatide for addiction A popular weight loss drug shows promise treating alcohol GLP-1 drugs may fight addiction

doi: 10.1056/NEJMoa0907118 Levy B et al (2018): Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction

Having an alternative treatment option could increase accessibility and acceptance given the lower adoption rate of existing FDA approved AUD medications

It has gained significant attention in regenerative medicine for its remarkable ability to accelerate the healing of diverse tissue types, including tendons, ligaments, and the lining of the gastrointestinal tract

Increased risk of low blood sugar when combined with a sulfonylurea or insulin

Individuals with MASH usually are asymptomatic in the early stages or present symptoms that are not closely related to the disease, leading to delayed diagnoses and treatment

Unlimited messaging with your physician via our secured HIPAA compliant chat system 5